Q0180 Dolasetron Mesylate - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Dolasetron Mesylate

Brand Name:

Anzemet

Strength:

100 mg

HCPCS:

Q0180

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Antiemetic

Minor Drug Class:

5HT3 Receptor Antagonist

Oral (Y/N):

Yes

FDA Approval Year:

1997

FDA Discontinuation Year:

CMS Effective Date:

April 1, 1998

CMS Discontinuation Date:

Status:

In Use